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The third HPLC allows separation of two close peaks (UV and RI detections), both of which reform the 
previous %peak equilibrium within 3 hours following their separation as can be checked by a control HPLC 
injection. Since the IR spectrum of the mixture showed an alcohol function, an acetylation was undertaken 
allowing isolation of a single product 2 as a colourless oil (5 le% of dry weight sample). 
Structural elucidation. On the basis of high resolution positive-ion LSIMS the empirical formula 
Ç$4205~, was established for sterol 2, thus revealing 9 Degrees of Unsaturation (DU). 
2959 
New Biologically Active Pectinoacetal-Related Sterols 
from the Gorgonian Ctenocella sp. 
X.C. FreM*, J.F. Biard, C. Roussakis and J.F. Verbist 
Institut dcs Substances et Organismes de Ia Mer (ISOMer), SMAB', BP 1024,44035 Nantes Cedex 01. France 
J. Vercauteren and N. Pinaud 
Labomtoin de Pharmacognosi~. Univmitk de Bordeaux II, Bilt 3A. 146 NC Lco Saignat. 33076 Bordeaux, France 
C. Ih?bitus 
ORSTOM, Ceme de Noum& BP A5, Noum& Cedcx, Nouvelle Cal6dook 
I .  
Abstract : Based on a bio-assay guided fractio~tio~, a new sterol has been isolated as an equilibrium of 
isomers 1 with interesting cancer cell antiproliferative properties from a yet undcscribcd species of the. 
genus Ctemcellu sp. The structure of this sterol has been inferred f" the acetyl derivative 2, on the 
basis of spectral shldy. Copyright Q 1996 Elsevier Science Ltd 
Gorgonians are a rich source of biologically active products among which are prostaglandins3.4, 
diterpenes3.5-7 (mainly briaranes and cembrenes), polymethylene butenolides8 and sterolsg. Several compounds 
have shown a broad range of potent bioactivities, mainly antimicrobiallo, anticancer11.12. and 
antiinfla"atory413. Ctenocella belongs to the little investigated Ellisellidae family (Cnidaria) which yielded 
usual sterols (Ellisella paraplexauroia'esg), juncins A-E (Junceella juncea14), junceellolides A-D (Junceella 
fragilisl3), junceellin and praelolide (Junceella squamata13), gemacolides A-E (Junceella gemmacea15) while 
Ctenocella pectinata yielded pectinoacetals A-CI6. 
Extraction The gorgonian, Ctenocella sp17 (2.3 kg, dry weight), has been collected off the New 
Caledonian coast in spring 1993 at a depth of 20 meters by the local ORSTOM branch. Samples were deep- 
freeze dried, blended and exhaustively extracted by 95% ethanol. The crude extract obtained was submitted to 
screening tests aimed inter alia at selecting organisms containing products inhibiting cancer cell proliferation 
@E318 and NSCLC19 clones). Since a positive result was observed (IC50=16.3 pg/mL on NSCLC and 3.9 
pg/mL on KF3 cells), the crude extract was submitted to solvent partition (hexane, CCl4, then CH2C12 YS 
water:methanol). As the Bioassay guided fractionation showed the most active fraction was the carbon 
tetrachloride soluble fraction, it was flash chromatographed over diol phase with elutions by CH2C12:MeOH 
(98:2) to (70:30). The first fraction (98:2) was then submitted to WLC fractionations on diol phase with 
isocratic elution by 1) CH2C12:MeOH (98:2), 2) hexane:CHzC12 (60:40), and 3) hexane:dioxane (76:24). 
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Fig. 1 : Acetyl derivative 2 
The carbon content was comoborated by J-modulated 
Fig. 2 : Partial spatial view of product 1 
13C NMR showing resonances that are readily 
assigned to an acetyl group (169.19 and 21.54 ppm), an enone system (199.11. 124.24 and 169.8 ppm), a 
pentacyclic keto group (216.41 ppm), an hemiacetal carbon (93.64 ppm) and an oxygenated 
methine(79.86ppm). In addition, this spectrum showed signals for six quatenmy, nine methine, nine methylene 
and five methyl carbons. 1H NMR data displayed 3 downfield shifted signals attributed to one ethylenic proton 
(H-4), one acetal proton (H-18) and one for a proton geminal to an oxygen (H-22). The W spectrum displays a 
characteristic band at 242 MI (~=17400, in CHC13) due to the enone system. The IR spectrum exhibits bands 
for the enone system (1672 cm-1: v C S ,  1617 cm-1: v C=C), the pentacyclic oxo group (1739 cm-I), the 
acetyl group (1225 cm-1) and the ether bond (1049 cm-1). Therefore 4 DU are directly attributed. 
13C NMR data, compared to 13C chemical shifts of numerous sterols, matched with the basic skeleton of 
testosterone for rings A and B, while they fitted better those of 5a-androstan-16-onez1 for rings C and D. Our 
experimental values are also very much in accordance with those of Roussis and Fenical, for pectinoacetals A- 
C16. However, in both cases there were discrepancies in carbon chemical shifts of ring D, and side chain. These 
facts led us to a sterol skeleton, with both C-18 and side chain modiied compared to the above mentioned 
products. The side chain shows the charactefitic isopropyl end group (IR : twin peaks at 1366 and 1376 cm-l? 
13C NMR : 22.25,22.81 and 27.91 ppm, 1H NMR : 0.85,0.87 and 1.51 ppm) as well as the C-21 methyl (14.96 
ppm). C-18 chemical shift is that of an hemiacetal and this is confirmed by an HMBC correlation between BI-18 
and the carboxyl group of the acetate. HMBC reveals further connectivities between C-18,H-22 and C-22,H-18. 
With regard to C-18 and C-22 downfield shifts, it was considered that both carbons are connected through an 
ether link All 9 DU are now accounted for, and we now have the assignments of all carbon chemical shifts. 
Even though 1H NMR spectra of sterols have been considered until recently as an “undecipherable, broad, 
almost featureless hump between -1 and 2.5 ppm”22, the systematic use of 500 MHZ and 2D NMR allow 
nearly complete 1H and 13C assignments. We have employed these techniques to support our structure proposal 
with a stereochemical insight, ie. conformation of the steroid skeleton and of the tetrahydropyran extra-ring. As 
can be seen from table 1, only eleven protons afford accurate coupling constant readings. All other signals 
overlap and cannot provide such information. However, signal width22 provides an indirect J evaluation 
(table 1) thus allowing a full 6 IH assignment tentative. On these asumptions we are able to propose the 
structure shown in figure 1. 
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Table 
c UC 
1 35.42 
2 33.84 
3 199.11 
4 124.24 
5 169.80 
6 32.35 
7 32.18 
8 34.38 
9 5352 
10 38.61 
11 21.29 
12 31.94 
13 46.01 
14 50.08 
15 38.85 
16 216.41 
17 60.78 
18 93.64 
19 17.38 
20 33.79 
21 14.96 
22 79.86 
23 31.79 
24 3454 
25 27.91 
26 22.25 
27 22.81 
Ac 169.19 
Ac 2154 
1H and 13C NMR Data of Acetylated Sterol 2 (CDC1+500 M H Z )  
EMQC H Cosy HMBC Jor signal Pattern width (&) designation 
2.04 la 2.44.2.36. 1.73 199.11,38.61,33.84, 17.37 13.4. 13.9.4.9 
1.73 
2.44 
2.36 
5.76 
2.43 
232 
1 .I35 
1.13 
1.87 
1.16 
1.68 
157 
252 
1.23 
1.61 
2.27 
2.23 
1.89 
6.06 
1.17 
a 
1.25 
3.4 
1.6 
135 
-b 
151 
0.85 
0.87 
18 
28 
2a 
4 
68 
78 
88 
6a 
7a  
9a  
l l a  
118 
128 
12a 
14a 
15a 
158 
17a 
18 
19 
U) 
21 
22 
23r 
23s 
24f 
25 
26 
27 - 
2.44.2.36.2.04 199.11.53.52,38.61.33.84, 17.37 
2.36,2.04, 1.73 199.11, 124.24.35.42 
2.44.2.04. 1.73 124.24 
2.44-2.32, 1.17 38.61,33.84,32.35 
2.32, 1.85, 1.13 169.8.32.18 
2.43.1.85, 1.13 169.8 
2.43.2.32. 1.85 50.08.34.38 
1.16, 1.61 
1.87, 1.68, 1.57 50.08,32.18.34.38,21.29. 17.37 
2.43.2.321.13 - 
2.52.1.57, 1.23, 1.16 - 
2.52, 1.68, 1.23. 1.16 53.52.46.01.31.94 
1.68.1.57, 1.23 46.01 
6.06.2.52, 1.68, 1.57 93.64.46.01.21.29 
2.27.2.23, 1.87 46.01.34.38 
2.23, 1.89, 1.61 216.41.50.08.34.38 
2.27. 1.61 216.41,50.08,34.38 
1.61, 1.95 216,93.64,79.86.46,33.79.31.94.14.96 
1.23 169.19,79.86.60.78,50.08,46.01,31.94 
5.76 169.8,53.52,38.61,35.42 
3.4, 1.25. 1.89 216.41,93.64,60.78.46.01,31.94, 14.96 
1.95 79.86,60.78,33.79 
1.95, 1.6, 1.35 
3.4, 1.35, 1.21 
3.4, 1.35, 1.21 27.91.22.81.22.25 
1.6, 151, 1.35 31.79,27.91,22.81,22.25 
1.35.0.87.0.85 22.81,22.25 
1.51 34.54.27.91.22.81.22.25 
1.51 34.54,27.91,22.81,22.25 
13.4.4.3.6 
3gC 
21.7c 
3gC 
21.F 
26.4c 
4 3 9  
39.V 
31.lC 
19.2c 
43.7c 
13.4.3.1 
35c 
33.6c 
18,8.4 
18.14 
4.2 
10.1.7.2.4.2 
7.2 
10.1.2.9 
21c.e 
32c*e 
d 
d 
7 
7 
lg. laa. lae 
lg, 1%. lec 
lglaalae 
lglaelce 
lglaalac 
lglaelee 
lglaelce 
lg2aalae 
3aalae 
2aaIaC 
lglaelec 
lg2aalae 
Ig, 1% lee 
lglaalae 
Ig, lac 
1g. laa 
2aalSe 
lae 
laa. lae, fr 
fr 
laa. H22-23 
d 
d 
fr 
lÌ 
bhsignments not visible in the spectrum, deduced from HMBC (1.95 ppm)a and (1.21 p m)b. 
“Signal width, dnot measurable or interpretable accurately, einterchangeable assignments , &o protons. 
g: geminal; aa: axial-axial; ae: axial-equatorial; ee: equatorial-equatoriak fr: free rotation. 
The clearly visible connectivity between H-18 and H - l h ,  implying a planar shape to allow a W 4J 
coupling, and the antiperiplanar coupling constant (J=10.1 Hz) displayed by H-22 can only be met if the 
tetrahydropyran ring is in chair conformation 2oC18, i.e. the anomeric proton is cc to the plane of the 
tetrahydropyrannyl ring. Moreover, in this conformation, the methyl-21 is located in the shielding cone of the 
carbonyl group, hence justifyiig its low chemical shift (14.96 ppm). 
This structure underlies the two-peak equilibrium observed during the final purification step. The extra- 
ring is generated by a lactol cyclisation between C-18 and C-22 involving an attack of the OH-22 on the Re face 
of the aldehyde we assume to be present at C-18a. An attack on the aldehyde Si face would of course lead to its 
epimer, but upon acetylation, prefered isomer 2 is the only formed product. 
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The previous study carried out on Ctenocella targeted pectinoacetals A, B and C on their W absorbance. 
Our study afforded ptinoacetal-related sterols based on biological activity. These sterols have only been 
reported in Ctenocella and could be considered as specific markers of this genus. Equilibrium-product 1 
showed cancer cell antiproliferative properties (IC50 = 0.23 pg/mL on KB cells, IC50 = 2.91glmL on NSCLC- 
N6 cells). A more detailed pharmacological study on 1 and 2 is under publication. 
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